Loading
journalsJournal
Clinical Pharmacology & Therapeutics
Clinical Pharmacology & Therapeutics is the ASCPT journal for dose optimisation, pharmacokinetics, drug interactions and pharmacogenomics, increasingly central to how oncology doses are chosen after FDA's Project Optimus.
Also called: Clin Pharmacol TherCPT
Overview
Clinical Pharmacology & Therapeutics (Clin Pharmacol Ther, CPT) is the journal of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), founded in 1960, appearing monthly and published by Wiley on a hybrid access model. It publishes clinical pharmacology of anticancer drugs, exposure-response and model-informed dosing, pharmacokinetics, drug-interaction and pharmacogenomic (CPIC) guidelines, and regulatory science commentary from FDA and EMA scientists. Its readers are clinical pharmacologists, trialists and regulators, and it has become increasingly central to how oncology doses are chosen after the FDA's Project Optimus. A reader of OnCo would use it for dose optimisation, drug-interaction and pharmacogenomic guidance relevant to cancer therapy.
Publisher
Wiley · American Society for Clinical Pharmacology and Therapeutics
Scope
pharmacology
Access model
hybrid
Founded
1960
ISSN
0009-9236
Similar pages
- TermRecommended phase 2 dose (RP2D)
Shares Maximum tolerated dose (MTD), Pharmacokinetics (PK), half-life and exposure, Project Optimus.
- JournalCancer biology & therapy
Shares Pharmacokinetics (PK), half-life and exposure, PubMed & Europe PMC.
- TermTherapeutic index (therapeutic window)
Shares Maximum tolerated dose (MTD), Pharmacokinetics (PK), half-life and exposure, Project Optimus.
- TermDose-limiting toxicity (DLT)
- TermDose-escalation designs (3+3, BOIN, dose-expansion)
- TermDose reduction, interruption and discontinuation
Shares Maximum tolerated dose (MTD), Pharmacokinetics (PK), half-life and exposure, Project Optimus.